4//SEC Filing
Andersson Claus A. 4
Accession 0001140361-21-037657
CIK 0001865494other
Filed
Nov 11, 7:00 PM ET
Accepted
Nov 12, 4:16 PM ET
Size
13.1 KB
Accession
0001140361-21-037657
Insider Transaction Report
Form 4
IO Biotech, Inc.IOBT
Andersson Claus A.
Director
Transactions
- Conversion
Common Stock
2021-11-09+1,361,660→ 1,361,660 total(indirect: See footnote) - Conversion
Series C Preferred Stock
2021-11-09−28,225→ 0 total(indirect: See footnote)→ Common Stock (354,830 underlying) - Conversion
Common Stock
2021-11-09+354,830→ 1,716,490 total(indirect: See footnote) - Conversion
Series B Preferred Stock
2021-11-09−147,881→ 0 total(indirect: See footnote)→ Common Stock (1,361,660 underlying) - Purchase
Common Stock
2021-11-09$14.00/sh+75,000$1,050,000→ 1,791,490 total(indirect: See footnote)
Footnotes (3)
- [F1]Upon the closing of the Issuer's initial public offering ("IPO"), each share of Series B Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into the number of shares of Common Stock reported in Column 7 of Table II. These shares of Series B Preferred Stock had no expiration date.
- [F2]Upon the closing of the IPO, each share of Series C Preferred Stock beneficially owned by the reporting person automatically converted, for no additional consideration, into the number of shares of Common Stock reported in Column 7 of Table II. These shares of Series C Preferred Stock had no expiration date.
- [F3]Sunstone Life Science Ventures Fund III K/S ("Sunstone Fund III"). Sunstone LSV General Partner III ApS ("Sunstone LSV GP III") is the general partner of Sunstone Fund III and has voting and dispositive power over all of the shares of held by Sunstone Fund III. The reporting person is a General Partner of Sunstone Life Science Ventures A/S and a member of the executive board of Sunstone LSV GP III, and shares voting and dispositive power with respect to the shares held by Sunstone Fund III. The reporting person disclaims beneficial ownership of the shares held directly by Sunstone Fund III except to the extent of his pecuniary interest therein.
Documents
Issuer
IO Biotech, Inc.
CIK 0001865494
Entity typeother
Related Parties
1- filerCIK 0001890710
Filing Metadata
- Form type
- 4
- Filed
- Nov 11, 7:00 PM ET
- Accepted
- Nov 12, 4:16 PM ET
- Size
- 13.1 KB